Melatonin decreases matrix metalloproteinase-9 activation and expression and attenuates reperfusion-induced hemorrhage following transient focal cerebral ischemia in rats

Journal of Pineal Research

Volumn 45, Issue 4, 2008, Pages 459-467

  Hung, Yu Chang ^a   Chen, Tsung Ying ^a,b   Lee, E Jian ^a   Chen, Wan Ling ^a   Huang, Sheng Yang ^a   Lee, Wei Ting ^a   Lee, Ming Yang ^a   Chen, Hung Yi ^a,c   Wu, Tian Shung ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Focal cerebral ischemia; Matrix metalloproteinase; Melatonin; Stroke

Indexed keywords

GELATINASE A; GELATINASE B; MELATONIN;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION SIZE; BRAIN PERFUSION; BRAIN PROTECTION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORE TEMPERATURE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; EXPERIMENTAL MODEL; FIBRINOLYTIC THERAPY; IMMUNOBLOTTING; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NONHUMAN; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SENSORIMOTOR FUNCTION; SPRAGUE DAWLEY RAT; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; BLOTTING, WESTERN; BRAIN; BRAIN INFARCTION; CEREBRAL HEMORRHAGE; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; ISCHEMIC ATTACK, TRANSIENT; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MELATONIN; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; STATISTICS, NONPARAMETRIC;

EID: 53749085742     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2008.00617.x     Document Type: Article

References (43)

1. Demaerschalk BM, Yip TR. Economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke in the United States. Stroke 2005 36 : 2500 2503.
2. Romanic AM, White RF, Arleth AJ et al. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 1998 29 : 1020 1030.
3. Chan PH. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 2001 21 : 2 14.
4. Zhao BQ, Ikeda Y, Ihara H et al. Essential role of endogenous tissue plasminogen activator through matrix metalloproteinase 9 induction and expression on heparin-produced cerebral hemorrhage after cerebral ischemia in mice. Blood 2004 103 : 2610 2616.
5. Gasche Y, Copin JC, Sugawara T et al. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J Cereb Blood Flow Metab 2001 21 : 1393 1400.
6. Chen TY, Lee MY, Chen HY et al. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice. J Pineal Res 2006 40 : 242 250.
7. Del Zoppo GJ, von Kummer R, Hammann GF. Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke. J Neurol Neurosurg Psychiatry 1998 65 : 1 9.
8. Lo EH, Dalkara T, Moskowitz MA. Mechanisms, challenges and opportunities in stroke. Nat Rev Neurosci 2003 4 : 399 415.
9. Asahi M, Asahi K, Jung JC et al. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 2000 20 : 1681 1689.
10. Rosenberg GA, Estrada EY, Dencoff JE. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 1998 29 : 2189 2195.
11. Heo JH, Lucero J, Abumiya T et al. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab 1999 19 : 624 633.
12. Rosenberg GA. Matrix metalloproteinases in neuroinflammation. Glia 2002 39 : 279 291.
13. Cheung RT. The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion. J Pineal Res 2003 34 : 153 160.
14. Cervantes M, Moralí G, Letechipía-Vallejo G Melatonin and ischemia-reperfusion injury of the brain. J Pineal Res 2008 in press. doi
15. Tan DX, Manchester LC, Terron MP et al. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007 42 : 28 42.
16. Manda K, Ueno M, Anzai K. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J Pineal Res 2007 42 : 386 393.
17. Guenther AL, Schmidt SI, Laatsch H et al. Reactions of the melatonin metabolite AMK (N1-acetyl-5-methoxykynuramine) with reactive nitrogen species: formation of novel compounds, 3-acetamidomethyl-6-methoxycinnolinone and 3-nitro-AMK. J Pineal Res 2005 39 : 251 260.
18. Rosen J, Than NN, Koch D et al. Interactions of melatonin and its metabolites with the ABTS cation radical: extension of the radical scavenger cascade and formation of a novel class of oxidation products, C2-substituted 3-indolinones. J Pineal Res 2006 41 : 374 381.
19. Lee EJ, Wu TS, Lee MY et al. Delayed treatment with melatonin enhances electrophysiological recovery following transient focal cerebral ischemia in rats. J Pineal Res 2004 36 : 33 42.
20. Lee EJ, Lee MY, Chen HY et al. Melatonin attenuates gray and white matter damage in a mouse model of transient focal cerebral ischemia. J Pineal Res 2005 38 : 42 52.
21. Chen HY, Chen TY, Lee MY et al. Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood-brain barrier permeability after transient focal cerebral ischemia in mice. J Pineal Res 2006 41 : 175 182.
22. Lee MY, Kuan YH, Chen HY et al. Intravenous administration of melatonin reduces the intracerebral cellular inflammatory response following transient focal cerebral ischemia in rats. J Pineal Res 2007 42 : 297 309.
23. Ganguly K, Maity P, Reiter RJ et al. Effect of melatonin on secreted and induced matrix metalloproteinase-9 and -2 activity during prevention of indomethacin-induced gastric ulcer. J Pineal Res 2005 39 : 307 315.
24. Ganguly K, Kundu P, Banerjee A et al. Hydrogen peroxide-mediated downregulation of matrix metalloprotease-2 in indomethacin-induced acute gastric ulceration is blocked by melatonin and other antioxidants. Free Radic Biol Med 2006 41 : 911 925.
25. Swarnakar S, Mishra A, Ganguly K et al. Matrix metalloproteinase-9 activity and expression is reduced by melatonin during prevention of ethanol-induced gastric ulcer in mice. J Pineal Res 2007 43 : 56 64.
26. Paul S, Sharma AV, Mahapatra PD et al. Role of melatonin in regulating matrix metalloproteinase-9 via tissue inhibitors of metalloproteinase-1 during protection against endometriosis. J Pineal Res 2008 44 : 439 449.
27. Esposito E, Genovese T, Caminiti R et al. Melatonin regulates matrix metalloproteinases after traumatic experimental spinal cord injury. J Pineal Res 2008 in press. doi
28. Lee EJ, Wu TS, Chang GL et al. Delayed treatment with nicotinamide inhibits brain energy depletion, improves cerebral microperfusion, reduces brain infarct volume, but does not alter neurobehavioral outcome following permanent focal cerebral ischemia in Sprague Dawley rats. Curr Neurovasc Res 2006 3 : 203 213.
29. Lee EJ, Lee MY, Chang GL et al. Delayed treatment with magnesium: reduction of brain infarction and improvement of electrophysiological recovery following transient focal cerebral ischemia in rats. J Neurosurg 2005 102 : 1085 1093.
30. Yeleswaram K, McLaughlin LG, Knipe JO et al. Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications. J Pineal Res 1997 22 : 45 51.
31. Pei Z, Pang SF, Cheung RT. Pretreatment with melatonin reduces volume of cerebral infarction in a rat middle cerebral artery occlusion stroke model. J Pineal Res 2002 32 : 168 172.
32. Pixinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. Academic Press, New York, 1982.
33. Clark WM, Rinker LG, Lessov NS et al. Lack of interleukin-6 expression is not protective against focal central nervous system ischemia. Stroke 2000 31 : 1715 1720.
34. Torii K, Uneyama H, Nishino H et al. Melatonin suppresses cerebral edema caused by middle cerebral artery occlusion/reperfusion in rats assessed by magnetic resonance imaging. J Pineal Res 2004 36 : 18 24.
35. Rosenberg GA, Cunningham LA, Wallace J et al. Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res 2001 893 : 104 112.
36. Beni SM, Kohen R, Reiter RJ et al. Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-kappaB and AP-1. FASEB J 2004 18 : 149 151.
37. Kratsovnik E, Bromberg Y, Sperling O et al. Oxidative stress activates transcription factor NF-kB-mediated protective signaling in primary rat neuronal cultures. J Mol Neurosci 2005 26 : 27 32.
38. Chetsawang B, Putthaprasart C, Phansuwan-Pujito P et al. Melatonin protects against hydrogen peroxide-induced cell death signaling in SH-SY5Y cultured cells: involvement of nuclear factor kappa B, Bax and Bcl-2. J Pineal Res 2006 41 : 116 123.
39. Esposito E, Iacono A, Muiá C et al. Signal transduction pathways involved in protective effects of melatonin in C6 glioma cells. J Pineal Res 2008 44 : 78 87.
40. Clark AW, Krekoski CA, Bou SS et al. Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci Lett 1997 238 : 53 56.
41. Tong L, Smyth D, Kerr C et al. Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts. Cell Signal 2004 16 : 1123 1132.
42. Guo M, Cox B, Mahale S et al. Pre-ischemic exercise reduces matrix metalloproteinase-9 expression and ameliorates blood-brain barrier dysfunction in stroke. Neuroscience 2008 151 : 340 351.
43. Kilic U, Kilic E, Reiter RJ et al. Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice. J Pineal Res 2005 38 : 67 71.